Hypercalcaemia
Hypercalcaemia, also spelled hypercalcemia, is a high calcium level in the blood serum. The normal range is 2.1–2.6 mmol/L, with levels greater than 2.6 mmol/L defined as hypercalcemia. Those with a mild increase that has developed slowly typically have no symptoms. In those with greater levels or rapid onset, symptoms may include abdominal pain, bone pain, confusion, depression, weakness, kidney stones or an abnormal heart rhythm including cardiac arrest.
Most cases are due to primary hyperparathyroidism or cancer. Other causes include sarcoidosis, tuberculosis, Paget disease, multiple endocrine neoplasia, vitamin D toxicity, familial hypocalciuric hypercalcaemia and certain medications such as lithium and hydrochlorothiazide. Diagnosis should generally include either a corrected calcium or ionized calcium level and be confirmed after a week. Specific changes, such as a shortened QT interval and prolonged PR interval, may be seen on an electrocardiogram.
Treatment may include intravenous fluids, furosemide, calcitonin or pamidronate in addition to treating the underlying cause. The evidence for furosemide use, however, is poor. In those with very high levels, hospitalization may be required. Haemodialysis may be used in those who do not respond to other treatments. In those with vitamin D toxicity, steroids may be useful. Hypercalcemia is relatively common. Primary hyperparathyroidism occurs in 1–7 per 1,000 people, and hypercalcaemia occurs in about 2.7% of those with cancer.
Signs and symptoms
The neuromuscular symptoms of hypercalcaemia are caused by a negative bathmotropic effect due to the increased interaction of calcium with sodium channels. Since calcium blocks sodium channels and inhibits depolarization of nerve and muscle fibers, increased calcium raises the threshold for depolarization. This results in diminished deep tendon reflexes, and skeletal muscle weakness.Other symptoms include cardiac arrhythmias, fatigue, nausea, vomiting, loss of appetite, abdominal pain, & paralytic ileus. If kidney impairment occurs as a result, manifestations can include increased urination, urination at night, and increased thirst. Psychiatric manifestation can include emotional instability, confusion, delirium, psychosis, and stupor. Calcium deposits known as limbus sign may be visible in the eyes.
Symptoms are more common at high calcium blood values. Severe hypercalcaemia is considered a medical emergency: at these levels, coma and cardiac arrest can result. The high levels of calcium ions decrease the neuron membrane permeability to sodium ions, thus decreasing excitability, which leads to hypotonicity of smooth and striated muscle. This explains the fatigue, muscle weakness, low tone and sluggish reflexes in muscle groups. The sluggish nerves also explain drowsiness, confusion, hallucinations, stupor or coma. In the gut this causes constipation. Hypocalcaemia causes the opposite by the same mechanism.
Hypercalcaemic crisis
A hypercalcaemic crisis is an emergency situation with a severe hypercalcaemia, generally above approximately 14 mg/dL.The main symptoms of a hypercalcaemic crisis are oliguria or anuria, as well as somnolence or coma. After recognition, primary hyperparathyroidism should be proved or excluded.
In extreme cases of primary hyperparathyroidism, removal of the parathyroid gland after surgical neck exploration is the only way to avoid death. The diagnostic program should be performed within hours, in parallel with measures to lower serum calcium. Treatment of choice for acutely lowering calcium is extensive hydration and calcitonin, as well as bisphosphonates.
Causes
and malignancy account for about 90% of cases of hypercalcaemia.Parathyroid function
- Primary hyperparathyroidism
- *Solitary parathyroid adenoma
- *Primary parathyroid hyperplasia
- *Parathyroid carcinoma
- *Multiple endocrine neoplasia
- *Familial isolated hyperparathyroidism
- Lithium use
- Familial hypocalciuric hypercalcemia/familial benign hypercalcemia
Cancer
- Solid tumour with metastasis
- Solid tumour with humoral mediation of hypercalcaemia
- Haematologic cancers
- Ovarian small cell carcinoma of the hypercalcemic type
Vitamin-D disorders
- Hypervitaminosis D
- Elevated 1,252D levels
- Idiopathic hypercalcaemia of infancy
- Rebound hypercalcaemia after rhabdomyolysis
High bone-turnover
- Hyperthyroidism
- Multiple myeloma
- Prolonged immobilization
- Paget's disease
- Thiazide use
- Vitamin A intoxication
Kidney failure
- Tertiary hyperparathyroidism
- Aluminium intoxication
- Milk-alkali syndrome
Other
- Acromegaly
- Adrenal insufficiency
- Zollinger–Ellison syndrome
Diagnosis
The normal range is 2.1–2.6 mmol/L, with levels greater than 2.6 mmol/L defined as hypercalcaemia. Moderate hypercalcaemia is a level of 2.88–3.5 mmol/L while severe hypercalcaemia is > 3.5 mmol/L.
ECG
Abnormal heart rhythms can also result, and ECG findings of a short QT interval suggest hypercalcaemia. Significant hypercalcaemia can cause ECG changes mimicking an acute myocardial infarction. Hypercalcaemia has also been known to cause an ECG finding mimicking hypothermia, known as an Osborn wave.Treatments
The goal of therapy is to treat the hypercalcaemia first and subsequently effort is directed to treat the underlying cause.Fluids and diuretics
Initial therapy:- hydration, increasing salt intake, and forced diuresis.
- *hydration is needed because many patients are dehydrated due to vomiting or kidney defects in concentrating urine.
- *increased salt intake also can increase body fluid volume as well as increasing urine sodium excretion, which further increases urinary potassium excretion.
- *after rehydration, a loop diuretic such as furosemide can be given to permit continued large volume intravenous salt and water replacement while minimizing the risk of blood volume overload and pulmonary oedema. In addition, loop diuretics tend to depress calcium reabsorption by the kidney thereby helping to lower blood calcium levels
- *can usually decrease serum calcium by 1–3 mg/dL within 24 hours
- *caution must be taken to prevent potassium or magnesium depletion
Bisphosphonates and calcitonin
- bisphosphonates are pyrophosphate analogues with high affinity for bone, especially areas of high bone-turnover.
- *they are taken up by osteoclasts and inhibit osteoclastic bone resorption
- *current available drugs include : etidronate, tiludronate, IV pamidronate, alendronate zoledronate and risedronate
- *all people with cancer-associated hypercalcaemia should receive treatment with bisphosphonates since the 'first line' therapy cannot be continued indefinitely nor is it without risk. Further, even if the 'first line' therapy has been effective, it is a virtual certainty that the hypercalcaemia will recur in the person with hypercalcaemia of malignancy. Use of bisphosphonates in such circumstances, then, becomes both therapeutic and preventative
- *people in kidney failure and hypercalcaemia should have a risk-benefit analysis before being given bisphosphonates, since they are relatively contraindicated in kidney failure.
- Calcitonin blocks bone resorption and also increases urinary calcium excretion by inhibiting calcium reabsorption by the kidney
- *Usually used in life-threatening hypercalcaemia along with rehydration, diuresis, and bisphosphonates
- *Helps prevent recurrence of hypercalcaemia
- *Dose is 4 international units per kilogram via subcutaneous or intramuscular route every 12 hours, usually not continued indefinitely due to quick onset of decreased response to calcitonin
Other therapies
- rarely used, or used in special circumstances
- *plicamycin inhibits bone resorption
- *gallium nitrate inhibits bone resorption and changes structure of bone crystals
- *glucocorticoids increase urinary calcium excretion and decrease intestinal calcium absorption
- **no effect on calcium level in normal or primary hyperparathyroidism
- **effective in hypercalcaemia due to osteolytic malignancies due to antitumour properties
- **also effective in hypervitaminosis D and sarcoidosis
- *dialysis usually used in severe hypercalcaemia complicated by kidney failure. Supplemental phosphate should be monitored and added if necessary
- *phosphate therapy can correct the hypophosphataemia in the face of hypercalcaemia and lower serum calcium
Other animals